The Rationale for Viscosupplementation

Are your Osteoarthritis Patients stuck in a revolving door, regularly re-presenting at your surgery with the same unresolved symptoms and complaints?

Does this sound familiar?
You suggest your symptomatic OA Patient tries conservative measures such as weight loss, exercise, simple analgesia
→ Patient tries, the measures fail, the Patient re-presents
→ Patient is sent to Physio/MSK
→ Physio' tries to help Patient lose weight and regain function
→ Patient can't engage with programme because of pain
→ Physiotherapy fails
→ Patient re-presents
→ Patient referred to Orthopaedics
→ Patient will not be considered for joint surgery due to being overweight or joint not sufficiently degenerated
→ Patient re-presents!

What else can you suggest? More physiotherapy? More pain killers?

Dr Edmund Willis, GP, in his British Journal of General Practice article of January 20151, says:

Knee replacement surgery is a very effective remedy, but can be risky, and quite a lot of patients are medically unfit for the procedure. Analgesics, systemic and topical nonsteroidal anti-inflammatory drugs, and intra-articular (IA) steroid injections provide limited or short-term benefits and physiotherapy and other conservative approaches may improve mobility but have less impact on pain.
Things are going to get worse in the future. Knee pain and disability are very strongly related to obesity, which, as we know, is rising fast.

About the risks involved in knee replacements, Dr Willis warns:

"Younger, and therefore more active patients, are at greater risk of implant failure, as are obese patients. There are around 5000 (6%) revisions out of 88 000 total procedures in England each year. However the need for revisions is bound to increase considerably with the increase in primary procedures and the tendency to operate on younger and more obese patients."

So, what is the solution to the dilemma?

Why not ask your local MSK Service if OSTENIL® PLUS could help these patients?

Does OSTENIL® actually work? Consider this:

  • One injection of OSTENIL® PLUS reduces pain and improves function in knee OA over 6 months.2

Or this:

  • Among patients with advanced OA of the shoulder who either refused or were considered medically unfit for shoulder replacement surgery, OSTENIL® reduced pain and improved function.3

OSTENIL® provides long-lasting pain relief and improves function in knee OA patients with excellent telerability.4

To conclude, we quote Dr Willis, GP, again:

"Perhaps it is time that we looked ahead a bit and considered how we should deal with the probable huge increase in the need for knee surgery, and actively explored alternative ways of dealing with it, one of which might be hyaluronan injections1."
  1. You can read the entire article by Dr Willis here (pdf):
    "The increasing demand for knee replacements: a hostage to fortune" by Dr Edmund Willis, GP.
  2. Borras Verdera A et al. Poster presented at the XXV triennial world congress of the International Society of Orthopedic and Traumatology. September 6-9, 2011.
  3. 3 Funk L et al. Presented at the 9th World Conference of the Osteoarthritis Research Society International 2004; poster P338.
  4. Moller I et al. Presented at the 6th World Conference of the Osteoarthritis Research Society International 2001; poster PB22



For more information on OSTENIL® PLUS please click here.
For further information or to arrange a visit by one of our representatives, please call us on 0845 330 7556, or email info@trbchemedica.co.uk.

You can now watch Dr Willis, GP, in this YouTube clip.

An interview with Dr Ted Willis, GP in Lincolnshire UK, on why he thinks viscosupplementation is still a viable treatment option for osteoarthritis. At the end of the video you can also watch him inject a patient's knee with OSTENIL PLUS.